dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Perez, Ariel |
dc.contributor.author | Iacoboni García-Calvo, Gloria |
dc.contributor.author | Penack, Olaf |
dc.contributor.author | Jentzsch, Liv |
dc.contributor.author | Carpio Segura, Cecilia Carmen |
dc.contributor.author | Barba Suñol, Pere |
dc.contributor.author | Rejeski, Kai |
dc.contributor.author | Bücklein, Veit |
dc.date.accessioned | 2022-09-06T12:22:15Z |
dc.date.available | 2022-09-06T12:22:15Z |
dc.date.issued | 2022-05 |
dc.identifier.citation | Rejeski K, Perez A, Iacoboni G, Penack O, Bücklein V, Jentzsch L, et al. The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. J Immunother Cancer. 2022 May;10(5):e004475. |
dc.identifier.issn | 2051-1426 |
dc.identifier.uri | https://hdl.handle.net/11351/8036 |
dc.description | Neoplàsies hematològiques; Receptors; Antigen quimèric |
dc.description.sponsorship | This work was supported by a Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) research grant provided within the Sonderforschungbereich SFB-TRR 388/1 2021-452881907, and DFG research grant 451580403 (to MS). The work was further supported by the Bavarian Elite Graduate Training Network (to MS), the Wilhelm-Sander Stiftung (to MS, project no. 20180871), the Else-Kröner-Fresenius Stiftung (to MS), and the Bavarian Center for Cancer Research (BZKF). |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | Journal for ImmunoTherapy of Cancer;10(5) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Cèl·lules B - Tumors - Tractament |
dc.subject | Immunoteràpia |
dc.subject | Antígens CD - Immunologia |
dc.subject.mesh | Lymphoma, Large B-Cell, Diffuse |
dc.subject.mesh | /therapy |
dc.subject.mesh | Immunotherapy, Adoptive |
dc.subject.mesh | Antigens, CD19 |
dc.title | The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/jitc-2021-004475 |
dc.subject.decs | linfoma de células B grandes difuso |
dc.subject.decs | /terapia |
dc.subject.decs | inmunoterapia adoptiva |
dc.subject.decs | antígenos CD19 |
dc.relation.publishversion | http://dx.doi.org/10.1136/jitc-2021-004475 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rejeski K] Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK) Munich Site, and German Cancer Research Center, Heidelberg, Germany. [Perez A] Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida, USA. Blood & Marrow Transplant Program, Miami Cancer Institute, Miami, Florida, USA. [Iacoboni G, Carpio C, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma of Barcelona, Bellaterra, Spain. [Penack O] Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. German Cancer Consortium (DKTK) Berlin Site, and German Cancer Research Center, Heidelberg, Germany. [Bücklein V] Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. [Jentzsch L] Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany |
dc.identifier.pmid | 35580927 |
dc.identifier.wos | 000797594100008 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |